Advice on treating rheumatic diseases from a COVID-19 epicenterMay 13, 2020COVID-19 UpdatesPediatricsPsoriatic Arthritis
ACR gives guidance on rheumatic disease management during pandemicMay 12, 2020COVID-19 UpdatesPsoriatic Arthritis
Case series suggests biologics, JAK inhibitors safe during pandemicMay 1, 2020Psoriatic ArthritisCOVID-19 UpdatesPsoriasis
Latest data on COVID-19 patients with rheumatic diseases revealed in registryApril 23, 2020COVID-19 UpdatesPediatricsPsoriasisPsoriatic Arthritis
Financial incentives affect the adoption of biosimilarsApril 16, 2020Business of MedicinePsoriatic ArthritisPsoriasis
‘We’re in great distress here,’ infusion center CMO saysApril 10, 2020COVID-19 UpdatesPsoriatic ArthritisPsoriasis
JAK inhibitors may increase risk of herpes zosterApril 7, 2020Infectious DiseasesMixed TopicsPsoriatic ArthritisPsoriasis
Genome study examines heritability of psoriatic disease subtypesApril 2, 2020Psoriatic ArthritisPsoriasis
Rapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experienceMarch 31, 2020Psoriatic ArthritisPediatricsPsoriasis
AAD-NPF releases first guidelines for nonbiologic treatments of psoriasisMarch 11, 2020PsoriasisPsoriatic Arthritis
Specific markers detect psoriatic disease inflammation without elevated CRPFebruary 25, 2020Psoriatic ArthritisPsoriasis
Nonspecific musculoskeletal symptoms might indicate early PsAFebruary 10, 2020Psoriatic ArthritisPsoriasis
